awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397403-0CEDA5DA-641A-414C-AD9D-83119157CE82
Q33397403-0CEDA5DA-641A-414C-AD9D-83119157CE82
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397403-0CEDA5DA-641A-414C-AD9D-83119157CE82
Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.
P2860
Q33397403-0CEDA5DA-641A-414C-AD9D-83119157CE82
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397403-0CEDA5DA-641A-414C-AD9D-83119157CE82
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b4bc70646affd4cc74a78406c6fb348762b0717
P2860
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].